Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Org Biomol Chem ; 16(1): 140-145, 2017 Dec 19.
Article in English | MEDLINE | ID: mdl-29218339

ABSTRACT

A facile and regioselective base-mediated aerobic oxidative acylation of nitroarenes to access diarylketones under mild conditions has been developed. It features the use of bench-stable and readily available arylacetates as acyl surrogates, and the absence of transition-metals and synthetic oxidants. This protocol involves a cascade CDC/oxidative decarboxylation process.

2.
Kaohsiung J Med Sci ; 28(4): 212-5, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22453069

ABSTRACT

This study investigated the clinical pathologic character of malignant gastrointestinal stromal tumors (MGIST), their treatment with surgery, and evaluated the efficacy of imatinib postoperation. A total of 68 MGIST patients were enrolled. Of these, 27 patients underwent imatinib auxiliary therapy (treatment group) and 41 underwent imatinib therapy (control group). The therapeutic effects on the two groups were compared using χ(2) test analysis after follow-up of two years. The expressions of CD117, CD34, S100, Vimentin, and alpha smooth-muscle actin (SMA) were detected by immunohistochemistry methods. Of the 68 cases, 28 showed potential MGIST, whereas 40 had MGIST. Haemorrhagia or necrosis, abundant cell, manifest heteromorphism, and caryocinesia were observed in varying degrees. The positive rates of CD117, CD34, Vimentin, S100, and SMA were 89.7% (61/62), 88.2% (60/62), 73.5% (50/62), 41.1% (28/62) and 25.0% (17/62), respectively. The recurrence rate in the treatment group was significantly lower than that in the control group (p < 0.01). We concluded that CD117 and CD34 may be the most valuable markers in the diagnosis of MGIST, and the diagnosis of MGIST depends on the pathology. Surgery is a far better approach in the treatment of such patients, and imatinib is the more efficient target drug in preventing recurrence and metastasis.


Subject(s)
Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/surgery , Adult , Aged , Female , Gastrectomy , Gastrointestinal Stromal Tumors/classification , Gastrointestinal Stromal Tumors/drug therapy , Humans , Immunohistochemistry , Male , Middle Aged
3.
Lung ; 190(3): 339-46, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22246551

ABSTRACT

BACKGROUND: Pulmonary cryptococcosis typically occurs in immunocompromised patients, but it can also occur in immunocompetent patients. Our objective was to describe the clinical manifestations, diagnosis, and management of primary pulmonary cryptococcosis in immunocompetent patients. METHODS: We retrospectively reviewed the clinical data of 76 patients with primary pulmonary cryptococcosis who were admitted to our hospital from 1995 to 2010. RESULTS: Pulmonary cryptococcosis was pathologically proven in all patients. Mean patient age was 42.5 years and 55 patients (72%) were male. The major clinical manifestations were cough (47 pts, 62%), expectoration (29 pts, 38%), fever (16 pts, 21%), chest pain (15 pts, 20%), dyspnea (17 pts, 22%), and emaciation (10 pts, 13%). Eighteen patients (24%) were asymptomatic. Most patients were admitted due to shadows on chest X-rays. Lesions were more common in the lower lung (60 pts, 78.9%) than in the upper lung (25 pts, 32.9%). More lesions (28 pts, 37%) were characterized by patchy consolidations. Pulmonary cryptococcosis was confirmed histologically among all patients. Surgical removal of lesions or treatment with fluconazole and other antifungal agents for complete courses led to favorable outcomes for most patients. CONCLUSIONS: Primary pulmonary cryptococcosis was found mainly in immunocompetent patients aged <50 years without preexisting lung disease. Shadow on the chest X-ray is the predominant feature. Treatment with a complete course of fluconazole and/or other antifungal agents can achieve favorable outcome.


Subject(s)
Cryptococcosis/diagnosis , Cryptococcus neoformans , Immunocompetence , Lung Diseases, Fungal/diagnosis , Adult , Antifungal Agents/therapeutic use , Chest Pain/etiology , Cough/etiology , Cryptococcosis/complications , Cryptococcosis/immunology , Cryptococcosis/therapy , Dyspnea/etiology , Emaciation/etiology , Female , Fever/etiology , Humans , Lung/surgery , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/immunology , Lung Diseases, Fungal/therapy , Male , Middle Aged , Retrospective Studies , Treatment Outcome
4.
Zhonghua Bing Li Xue Za Zhi ; 39(8): 522-7, 2010 Aug.
Article in Chinese | MEDLINE | ID: mdl-21055030

ABSTRACT

OBJECTIVE: To study the clinicopathologic features of follicular dendritic cell sarcoma (FDCS) and its differential diagnosis. METHODS: Ten cases of FDCS were studied by light microscopy, immunohistochemistry and in-situ hybridization. The clinical features and follow-up information were analyzed. RESULTS: Amongst the 10 cases of FDCS studied, the male-to-female ratio was 1:1. The mean age of the patients was 42 years. Six of them were located in cervical and peritoneal lymph nodes and four in extranodal sites (including tonsil, pelvic cavity, tail of pancreas and spleen). Histologically, the tumor cells had whorled, storiform or diffuse growth patterns. They were spindle in shape and contained syncytial eosinophilic cytoplasm, with round or oval nuclei, vesicular chromatin, distinct nucleoli and a variable number of mitotic figures. Multinucleated tumor giant cells and intranuclear pseudoinclusions were occasionally seen. There was a sprinkling of small lymphocytes and neutrophils within the tumor as well as in the perivascular region. Immunohistochemical study showed that the tumor cells were diffusely or focally positive for CD21, CD23, CD35 and D2-40, but negative for LCA, CD20, CD3, CD1a, HMB45 and CK. Some of them showed EMA, CD68 and S-100 reactivity. In-situ hybridization for Epstein-Barr virus-encoded RNA (EBER) showed positive signals in only one case (which was diagnosed as inflammatory pseudotumor-like FDCS). Of the 7 patients with follow-up information available (duration: 2 months to 39 months; mean: 14 months), 2 cases with paraneoplastic pemphigus died of pulmonary infection at 5 and 7 months respectively. The remaining 5 patients were alive and disease-free after surgical excision (+/- chemotherapy and radiotherapy). CONCLUSIONS: FDCS is a rare low to intermediate-grade malignant tumor. Appropriate application of FDC markers, such as CD21, CD35 and D2-40, would be helpful for arriving at a correct diagnosis. Most cases are associated with good prognosis after surgical treatment, with or without chemotherapy and radiotherapy. Patients with paraneoplastic pemphigus carry a less favorable prognosis.


Subject(s)
Dendritic Cell Sarcoma, Follicular/pathology , Lymph Nodes/pathology , Tonsillar Neoplasms/pathology , Adult , Antibodies, Monoclonal, Murine-Derived/metabolism , Dendritic Cell Sarcoma, Follicular/complications , Dendritic Cell Sarcoma, Follicular/metabolism , Dendritic Cell Sarcoma, Follicular/surgery , Dendritic Cell Sarcoma, Interdigitating/pathology , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Lymph Node Excision , Lymph Nodes/surgery , Male , Meningioma/pathology , Middle Aged , Nasopharyngeal Neoplasms/pathology , Paraneoplastic Syndromes/complications , Pemphigus/complications , Receptors, Complement 3b/metabolism , Receptors, Complement 3d/metabolism , Receptors, IgE/metabolism , Tonsillar Neoplasms/metabolism , Tonsillar Neoplasms/surgery , Young Adult
6.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(1): 177-8, 2009 Jan.
Article in Chinese | MEDLINE | ID: mdl-19218142

ABSTRACT

OBJECTIVE: To observe the clinical effects of partial revascularization on elderly patients with coronary artery diseases(CAD) METHODS: Percutaneous coronary interventions (PCI) of the most likely culprit vessels were performed in 37 patients over 80 years old with multivessel coronary artery diseases (CAD). RESULTS: The success rate of PCI was 100% in these elderly patients without serious complications. The in-hospital mortality rate was 2.7%, and all the other patients recovered and were discharged. CONCLUSION: Partial revascularization for elderly CAD patients can achieve satisfactory clinical results, and close attention should be given to the heart and kidney function of these patients.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Artery Disease/therapy , Stents , Age Factors , Aged , Aged, 80 and over , Angioplasty, Balloon, Coronary/methods , Female , Humans , Male , Risk Factors
7.
Zhonghua Wei Chang Wai Ke Za Zhi ; 9(5): 409-11, 2006 Sep.
Article in Chinese | MEDLINE | ID: mdl-17043962

ABSTRACT

OBJECTIVE: To investigate the clinicopathological characteristics, and treatment of malignant gastrointestinal stromal tumors (MGIST). METHODS: Immunohistochemistry was used to detect CD117, CD34, S100, vimentin and SMA expressions. The postoperative curative effect was compared between the patients with or without imatinib treatment. RESULTS: Radical resection was performed in 60 cases. Twenty-two tumors with a mean diameter of 5.3 cm were potentially malignant, and 38 tumor with a mean diameter of 9.2 cm were malignant. Microscopical examination revealed haemorrhagia or necrosis, abundant tumor cells, heteromorphism and caryocinesia of the tumors. 54 Cases were CD117 positive, 53 cases CD34 positive, 48 cases vimentin positive, 27 cases S100 positiveì16 cases SMA positive. The two-year recurrence rate was 80.5% in the patients without postoperative imatinib treatment, significantly higher than 21.1% in the patients with postoperative imatinib treatment(P< 0.05). CONCLUSIONS: CD117 and CD34 markers are most valuable diagnostic indexes of MGIST, but its final diagnosis depends on pathology. Postoperative imatinib treatment is most effective to control recurrence and metastasis.


Subject(s)
Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/therapy , Adult , Aged , Antigens, CD34/metabolism , Antineoplastic Agents/therapeutic use , Benzamides , Female , Humans , Imatinib Mesylate , Male , Middle Aged , Piperazines/therapeutic use , Proto-Oncogene Proteins c-kit/metabolism , Pyrimidines/therapeutic use , Retrospective Studies
8.
Zhonghua Zheng Xing Wai Ke Za Zhi ; 20(5): 330-2, 2004 Sep.
Article in Chinese | MEDLINE | ID: mdl-15623096

ABSTRACT

OBJECTIVE: To explore the correlation between breast carcinoma and silicone gel injection for breast augmentation. METHODS: Four cases of breast cancer after silicone gel injection were studied by means of clinical pathological analysis. RESULTS: In the four women, breast lump of over 5 cm in diameter was found half year to 2 years after silicone injection. The tumor was misdiagnosed to inflammatory reaction of silicone gel injection. Definite diagnosis was made by histological examinations, which showed there was mucoid, light blue and well-distributed silicone gel among the nests of neoplasm cells. Lymph node metastasis of cancer cells was observed. CONCLUSIONS: Silicone gel injection to the breast may be a reason for evoking or accelerating breast cancer. Breast cancer that occurred after breast augmentation with silicone gel injection could be misdiagnosed. Final diagnosis depends on biopsy. Silicone gel injection for breast augmentation should be abandoned.


Subject(s)
Breast Neoplasms/etiology , Mammaplasty/adverse effects , Silicone Gels/adverse effects , Adult , Breast/pathology , Breast/surgery , Breast Neoplasms/diagnosis , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Middle Aged , Silicone Gels/therapeutic use
9.
Zhonghua Bing Li Xue Za Zhi ; 33(4): 354-7, 2004 Aug.
Article in Chinese | MEDLINE | ID: mdl-15363323

ABSTRACT

OBJECTIVE: To evaluate the progression in morphologic changes of lungs in SARS patients. METHODS: Four cases of SARS with lung tissue samples available (including one for ultrastructural examination) were enrolled into the study. Histochemical study for VG, Masson, reticulin, orcein, PAS, sirius red stains and immunohistochemical study for vimentin, desmin, smooth muscle actin, HHF-35, CD34, F8, collagen types I and III were also performed. RESULTS: According to the morphologic changes, lung lesions in SARS were subcategorized into 3 phases: acute exudative inflammation, fibrous proliferation and the final fibrotic stage. Two cases belonged to the acute exudative phase, in which the course was less than 20 days. The principal lesions consisted of acute alveolar exudative inflammation, hyperplasia of alveolar epithelium, necrosis, alveolar hyaline membrane formation, alveolar desquamation and focal fibroplasia. The acute exudative protein was PAS-positive. There was an increase in reticulin fiber formation. The reactive fibroblasts were highlighted by desmin and vimentin. One case belonged to the fibroproliferative stage, in which the course was around 25 days. Major lesions included proliferative interstitial pneumonia with early pulmonary fibrosis. There was also evidence of organizing pneumonia, with an increase in reticulin fiber formation, which had a glomeruloid appearance on special stain. The mesenchymal cells showed either myofibroblastic (which expressed desmin, HHF-35, smooth muscle actin and vimentin) or fibroblastic (which expressed vimentin only) differentiation. Fibroelastosis and fibroplasia was also noted. The remaining case belonged to the fibrotic stage, in which the course was around 75 days. The main features included diffuse fibrosis and honeycomb change, which were highlighted by sirius red stain. Immunohistochemistry showed mainly types I and IV collagen fibers. In all lesions, there was also an increase of number of CD68-positive macrophages. CONCLUSIONS: The morphologic progression in lungs of SARS patients is characterized by the development of increased fibrosis. The primitive mesenchymal cells, hyperplastic alveolar epithelial cells and macrophages play an important role in the pathogenesis.


Subject(s)
Lung/pathology , Severe Acute Respiratory Syndrome/pathology , Actins/metabolism , Adult , Collagen Type I/metabolism , Desmin/metabolism , Humans , Lung/metabolism , Male , Middle Aged , Pulmonary Fibrosis/pathology , Severe Acute Respiratory Syndrome/metabolism , Vimentin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...